To achieve capital growth.
Name | % Net Assets |
---|---|
Vodafone | 6.9% |
Royal Dutch Shell | 6.9% |
BP | 5.2% |
AstraZeneca | 4.8% |
HSBC | 4.5% |
GlaxoSmithKline | 4.3% |
Barclays | 3.9% |
British American Tobacco | 3.5% |
RSA Group | 3.0% |
Pearson | 2.9% |
Key | % Net Assets |
---|---|
Vodafone | 6.9% |
Royal Dutch Shell | 6.9% |
BP | 5.2% |
AstraZeneca | 4.8% |
Other | 76.2% |
Date | 21-Nov-2024 |
---|---|
NAV | 218.59p |
Currency | GBP |
Change | -0.53p |
% | -0.24% |
YTD change | 5.01p |
YTD % | 2.35% |
Fund Inception | 03/06/1996 |
---|---|
Fund Manager | Ben Whitmore |
TER | 1.76 (31-Oct-2013) |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | n/a |
Savings | £100 |
Charges | |
---|---|
Initial | 5.25% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.10 |
You are here: research